Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPB-SNB for Postoperative Recovery in Lower Extremity Orthopaedic Surgeries
NCT06301503Phase 3Completed
- Sponsor
- Udayana University
- Start
- Mar 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Udayana University. Primary endpoint: Postoperative Quality of Recovery. Started Mar 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06301503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06301503.